Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure
Open Access
- 30 April 2020
- journal article
- research article
- Published by Wiley in ESC Heart Failure
- Vol. 7 (4), 1571-1584
- https://doi.org/10.1002/ehf2.12706
Abstract
Aims The effects of GRK2 inhibition on myocardial metabolism in heart failure (HF) are unchartered. In this work, we evaluated the impact of pharmacological inhibition of GRK2 by a cyclic peptide, C7, on metabolic, biochemical, and functional phenotypes in experimental HF. Methods and results C7 was initially tested on adult mice ventricular myocyte from wild type and GRK2 myocardial deficient mice (GRK2‐cKO), to assess the selectivity on GRK2 inhibition. Then, chronic infusion of 2 mg/kg/day of C7 was performed in HF mice with cryogenic myocardial infarction. Cardiac function in vivo was assessed by echocardiography and cardiac catheterization. Histological, biochemical, and metabolic studies were performed on heart samples at time points. C7 induces a significant increase of contractility in wild type but not in adult ventricle myocytes from GRK2‐cKO mice, thus confirming C7 selectivity for GRK2. In HF mice, 4 weeks of treatment with C7 improved metabolic features, including mitochondrial organization and function, and restored the biochemical and contractile responses. Conclusions GRK2 is a critical molecule in the physiological regulation of cardiac metabolism. Its alterations in the failing heart can be pharmacologically targeted, leading to the correction of metabolic and functional abnormalities observed in HF.Keywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca (2017HTKLRF)
This publication has 37 references indexed in Scilit:
- CaMK4 Gene Deletion Induces HypertensionJournal of the American Heart Association, 2012
- AAV6-βARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserveThe Journal of Thoracic and Cardiovascular Surgery, 2012
- G Protein–Coupled Receptor Kinase 2 Activity Impairs Cardiac Glucose Uptake and Promotes Insulin Resistance After Myocardial IschemiaCirculation, 2011
- A Novel and Efficient Model of Coronary Artery Ligation and Myocardial Infarction in the MouseCirculation Research, 2010
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Reduction of Sympathetic Activity via Adrenal-targeted GRK2 Gene Deletion Attenuates Heart Failure Progression and Improves Cardiac Function after Myocardial InfarctionJournal of Biological Chemistry, 2010
- An adrenal β-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivoProceedings of the National Academy of Sciences of the United States of America, 2009
- Myocardial Adeno-Associated Virus Serotype 6–βARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart FailureCirculation, 2009
- Energy metabolism in heart failure and remodellingCardiovascular Research, 2008